Total Debt
$2.4M
Net Debt
-$349.5M
Cullinan Therapeutics, Inc. currently has $2.4M in total debt. Net debt is -$349.5M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
CGEM • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.35 | -0.35Net Cash | 0.40 | 0.6% |
| 2025-12-31 | 0.00 | 0.38 | -0.38Net Cash | 0.45 | 0.6% |
| 2025-09-30 | 0.00 | 0.33 | -0.33Net Cash | 0.48 | 0.2% |
| 2025-06-30 | 0.00 | 0.27 | -0.26Net Cash | 0.52 | 0.3% |
| 2025-03-31 | 0.00 | 0.30 | -0.30Net Cash | 0.58 | 0.3% |
| 2024-12-31 | 0.00 | 0.40 | -0.40Net Cash | 0.62 | 0.3% |
| 2024-09-30 | 0.00 | 0.58 | -0.58Net Cash | 0.65 | 0.4% |
| 2024-06-30 | 0.00 | 0.66 | -0.66Net Cash | 0.68 | 0.4% |
| 2024-03-31 | 0.00 | 0.43 | -0.43Net Cash | 0.45 | 0.7% |
| 2023-12-31 | 0.00 | 0.47 | -0.46Net Cash | 0.48 | 0.7% |
| 2023-09-30 | 0.01 | 0.47 | -0.46Net Cash | 0.49 | 1.2% |
| 2023-06-30 | 0.01 | 0.49 | -0.49Net Cash | 0.52 | 1.2% |
| 2023-03-31 | 0.01 | 0.39 | -0.38Net Cash | 0.51 | 1.3% |
| 2022-12-31 | 0.01 | 0.47 | -0.46Net Cash | 0.56 | 0.9% |
| 2022-09-30 | 0.00 | 0.58 | -0.57Net Cash | 0.62 | 0.8% |
| 2022-06-30 | 0.00 | 0.61 | -0.61Net Cash | 0.67 | 0.2% |
| 2022-03-31 | 0.00 | 0.31 | -0.31Net Cash | 0.44 | 0.5% |
| 2021-12-31 | 0.00 | 0.29 | -0.29Net Cash | 0.44 | 0.0% |
| 2021-09-30 | 0.00 | 0.32 | -0.32Net Cash | 0.45 | 0.0% |
| 2021-06-30 | 0.00 | 0.34 | -0.34Net Cash | 0.46 | 0.0% |
| 2021-03-31 | 0.00 | 0.44 | -0.44Net Cash | 0.48 | 0.0% |
| 2020-12-31 | 0.00 | 0.21 | -0.21Net Cash | 0.21 | 0.0% |
| 2020-09-30 | 0.00 | 0.22 | -0.22Net Cash | 0.22 | 0.0% |
| 2020-06-30 | 0.00 | 0.10 | -0.10Net Cash | 0.10 | 0.0% |
| 2020-03-31 | 0.00 | 0.10 | -0.10Net Cash | 0.00 | — |
| 2019-12-31 | 0.00 | 0.10 | -0.10Net Cash | 0.10 | 0.0% |
| 2019-03-31 | 0.00 | 0.03 | -0.03Net Cash | 0.00 | — |